共 27 条
[1]
Marazzi F(2020)Diagnosis and treatment of bone metastases in breast cancer: radiotherapy, local approach and systemic therapy in a guide for clinicians Cancers (Basel) 12 2390-e149
[2]
Rossi L(2020)State of art and advances on the treatment of bone metastases from breast cancer: a concise review Chin Clin Oncol 9 18-1649
[3]
Sathiakumar N(2017)Accuracy of medicare claim-based algorithm to detect breast, prostate, or lung cancer bone metastases Med Care 55 e144-229
[4]
Cardoso F(2020)5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) Ann Oncol 31 1623-1747
[5]
Guo W(2018)Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma (2018) Chin J Oncol. 9 703-147
[6]
Hao B(2018)Early re-staging and molecular subtype shift surveillance of locally recurrent or metastatic breast cancer: A new PET/CT integrated precise algorithm Cancer Lett 418 221-1311
[7]
Goldhirsch A(2018)Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using (18)F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy BMC Cancer 18 1192-555
[8]
Sharma P(2011)Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer 2011 Ann Oncol 22 1736-765
[9]
Garcia Vicente AM(2012)Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management Nucl Med Commun 33 139-393
[10]
Haynes B(2013)Molecular subtypes of breast cancer: metabolic correlation with (1)(8)F-FDG PET/CT Eur J Nucl Med Mol Imaging 40 1304-193